Our study showed that berberine reduces myocardial injury, and enhances myocardial contraction and diastolic function to alleviate SCM in sepsis rats, by inhibiting sepsis-induced TLR4/NF-κB signal pathway activation and decreasing the expression levels of TNF-α, IL-1β and other inflammatory factors. The gene discussed is NFKB1; the disease is Sepsis.